Literature DB >> 11981371

High incidence of HIV-1 in South Africa using a standardized algorithm for recent HIV seroconversion.

Eleanor Gouws1, Brian G Williams, Haynes W Sheppard, Barryett Enge, Salim Abdool Karim.   

Abstract

Southern Africa has among the highest rates of HIV-1 infection in the world as judged by cross-sectional HIV-1 prevalence surveys carried out among women attending antenatal clinics. Incidence rates, which provide information on the number of new cases of infection, are more informative of the current state of the epidemic than estimates of prevalence, which provide information on the rates averaged over some previous time. Cohort studies to measure incidence rates are expensive and difficult to carry out, however, and few have been done in Africa. A recently developed standardized algorithm for recent HIV-1 seroconversion (STARHS) based on a sensitive/less-sensitive enzyme-linked immunosorbent assay was used to determine the incidence of HIV-1 subtype C infection among women attending public sector antenatal clinics in Hlabisa, a rural district in KwaZulu-Natal, South Africa. The STAHRS results were confirmed by using a mathematic model to obtain an independent estimate of the age-specific incidence rates from the age-specific prevalence data. The data reveal extraordinarily high HIV-1 incidence rates in South Africa. In 1999, the annual incidence of HIV-1 among susceptible women aged 15 to 49 years standardized to the age distribution of adult women in Hlabisa was 17%. Incidence peaked among 22-year-old women at 24% per year. The HIV-1 incidence rates provide valuable additional information indicating that new infections are continuing unabated and that the HIV-1 epidemic is still growing in rural South Africa.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11981371     DOI: 10.1097/00126334-200204150-00015

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  14 in total

1.  HIV epidemic trend and antiretroviral treatment need in Karonga District, Malawi.

Authors:  R G White; E Vynnycky; J R Glynn; A C Crampin; A Jahn; F Mwaungulu; O Mwanyongo; H Jabu; H Phiri; N McGrath; B Zaba; P E M Fine
Journal:  Epidemiol Infect       Date:  2007-01-12       Impact factor: 2.451

2.  Sexual health, HIV risk, and retention in an adolescent HIV-prevention trial preparatory cohort.

Authors:  Heather B Jaspan; Alan J Flisher; Landon Myer; Catherine Mathews; Keren Middelkoop; Daniella Mark; Linda-Gail Bekker
Journal:  J Adolesc Health       Date:  2011-03-12       Impact factor: 5.012

3.  The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine design.

Authors:  Marcus Altfeld; Todd M Allen; Elizabeth T Kalife; Nicole Frahm; Marylyn M Addo; Bianca R Mothe; Almas Rathod; Laura L Reyor; Jason Harlow; Xu G Yu; Beth Perkins; Loren K Robinson; John Sidney; Galit Alter; Mathias Lichterfeld; Alessandro Sette; Eric S Rosenberg; Philip J R Goulder; Christian Brander; Bruce D Walker
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  Epidemiological impact of tenofovir gel on the HIV epidemic in South Africa.

Authors:  Brian G Williams; Salim S Abdool Karim; Quarraisha Abdool Karim; Eleanor Gouws
Journal:  J Acquir Immune Defic Syndr       Date:  2011-10-01       Impact factor: 3.731

5.  Comparison of the avidity index method and the serologic testing algorithm for recent human immunodeficiency virus (HIV) seroconversion, two methods using a single serum sample for identification of recent HIV infections.

Authors:  Elisa Martró; Barbara Suligoi; Victoria González; Vincenzo Bossi; Anna Esteve; Joanne Mei; Vicenç Ausina
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

6.  Evaluation of HIV incidence surveillance in New York City, 2006.

Authors:  Hemanth P Nair; Lucia V Torian; Lisa Forgione; Elizabeth M Begier
Journal:  Public Health Rep       Date:  2011 Jan-Feb       Impact factor: 2.792

7.  Rate and incidence estimates of recent human immunodeficiency virus type 1 infections among pregnant women in Sao Paulo, Brazil, from 1991 to 2002.

Authors:  Carmem A de Freitas Oliveira; Mirthes Ueda; Rosemeire Yamashiro; Rosângela Rodrigues; Haynes W Sheppard; Luís Fernando de Macedo Brígido
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

8.  Comparison of the human immunodeficiency virus (HIV) type 1-specific immunoglobulin G capture enzyme-linked immunosorbent assay and the avidity index method for identification of recent HIV infections.

Authors:  Stephan Loschen; Jörg Bätzing-Feigenbaum; Gabriele Poggensee; Christiane Cordes; Bettina Hintsche; Michael Rausch; Stephan Dupke; Silvia Gohlke-Micknis; Jana Rödig; Osamah Hamouda; Claudia Kücherer
Journal:  J Clin Microbiol       Date:  2007-10-31       Impact factor: 5.948

9.  The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C.

Authors:  Tonie Cilliers; Jabulani Nhlapo; Mia Coetzer; Dragana Orlovic; Thomas Ketas; William C Olson; John P Moore; Alexandra Trkola; Lynn Morris
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

10.  External infections contribute minimally to HIV incidence among HIV sero-discordant couples in sub-Saharan Africa.

Authors:  Hiam Chemaitelly; Laith J Abu-Raddad
Journal:  Sex Transm Infect       Date:  2012-08-28       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.